|
2016-06-10 |
2016-06-08 |
S
Sale
|
Sheahan Brian
VP, Regulatory, Clinical & QA
Officer
|
166
-3.0%
3.99
USD 662
|
166
-3.0%
|
3.99
|
USD 662
|
|
|
2016-06-10 |
2016-06-08 |
S
Sale
|
Vance Cary Guy
President and CEO
Executive Director
|
596
-3.7%
3.99
USD 2,378
|
596
-3.7%
|
3.99
|
USD 2,378
|
|
|
2016-03-09 |
2016-03-07 |
S
Sale
|
Sheahan Brian
VP, Regulatory, Clinical & QA
Officer
|
161
-3.0%
2.51
USD 404
|
161
-3.0%
|
2.51
|
USD 404
|
|
|
2016-02-17 |
2016-02-12 |
S
Sale
|
Guido Joseph James
VP, Marketing & Business Dev
Officer
|
2,000
-30.7%
2.34
USD 4,680
|
2,000
-30.7%
|
2.34
|
USD 4,680
|
|
|
2016-02-17 |
2016-02-12 |
S
Sale
|
Cathcart Robert O
SVP, Global Sales
Officer
|
284
-28.3%
2.34
USD 665
|
284
-28.3%
|
2.34
|
USD 665
|
|
|
2016-02-17 |
2016-02-12 |
S
Sale
|
Sheahan Brian
VP, Regulatory, Clinical & QA
Officer
|
3,472
-40.9%
2.34
USD 8,124
|
3,472
-40.9%
|
2.34
|
USD 8,124
|
|
|
2015-05-14 |
2015-05-12 |
B
Purchase
|
FEINBERG LARRY N
Large shareholder
|
2,361,342
+92.0%
0.65
USD 1,534,872
|
2,361,342
+92.0%
|
0.65
|
USD 1,534,872
|
|
|
2015-05-14 |
2015-05-12 |
B
Purchase
|
FEINBERG LARRY N
Large shareholder
|
3,934,886
+85.4%
0.65
USD 2,557,676
|
3,934,886
+85.4%
|
0.65
|
USD 2,557,676
|
|
|
2015-05-14 |
2015-05-12 |
B
Purchase
|
FEINBERG LARRY N
Large shareholder
|
12,592,453
+68.8%
0.65
USD 8,185,094
|
12,592,453
+68.8%
|
0.65
|
USD 8,185,094
|
|
|
2015-03-11 |
2015-03-09 |
B
Purchase
|
Schuler Family Foundation
Large shareholder
|
23,077
+inf%
650.00
USD 15,000,050
|
23,077
+inf%
|
650.00
|
USD 15,000,050
|
|
|
2014-12-10 |
2014-12-10 |
B
Purchase
|
Yared Nadim
Non-Executive Director
|
15,000
+46.9%
0.65
USD 9,750
|
15,000
+46.9%
|
0.65
|
USD 9,750
|
|
|
2014-12-03 |
2014-12-03 |
B
Purchase
|
Sutton William Mitchell
Chief Operating Officer
Officer
|
25,000
+inf%
0.75
USD 18,805
|
25,000
+inf%
|
0.75
|
USD 18,805
|
|
|
2014-11-12 |
2014-11-12 |
B
Purchase
|
Vance Cary Guy
President and CEO
Executive Director
|
75,000
+inf%
0.83
USD 61,995
|
75,000
+inf%
|
0.83
|
USD 61,995
|
|
|
2014-05-20 |
2014-05-20 |
B
Purchase
|
LOWE CHRISTOPHER P.
Interim CEO
Executive Director
|
20,000
+88.9%
1.44
USD 28,890
|
20,000
+88.9%
|
1.44
|
USD 28,890
|
|
|
2014-05-14 |
2014-05-13 |
B
Purchase
|
BOWEN MARJORIE L.
Non-Executive Director
|
9,789
+12.6%
1.27
USD 12,473
|
9,789
+12.6%
|
1.27
|
USD 12,473
|
|
|
2014-05-14 |
2014-05-13 |
B
Purchase
|
EAGLE MICHAEL L
Non-Executive Director
|
10,000
+61.5%
1.20
USD 12,000
|
10,000
+61.5%
|
1.20
|
USD 12,000
|
|
|
2014-05-13 |
2014-05-13 |
B
Purchase
|
Newman Stephen L
Non-Executive Director
|
8,000
+6.6%
1.19
USD 9,519
|
8,000
+6.6%
|
1.19
|
USD 9,519
|
|
|
2014-05-13 |
2014-05-13 |
B
Purchase
|
Yared Nadim
Non-Executive Director
|
2,143
+10.7%
1.19
USD 2,550
|
2,143
+10.7%
|
1.19
|
USD 2,550
|
|
|
2014-03-12 |
2014-03-11 |
B
Purchase
|
EAGLE MICHAEL L
Non-Executive Director
|
10,000
+160.0%
2.29
USD 22,900
|
10,000
+160.0%
|
2.29
|
USD 22,900
|
|
|
2014-03-05 |
2014-03-03 |
S
Sale
|
Jacob Rita V.
VP Training & Clinical Affairs
Officer
|
35,589
-100.0%
2.35
USD 83,634
|
35,589
-100.0%
|
2.35
|
USD 83,634
|
|
